[ESPR] YoY Quarter Result on 31-Dec-2012 [#Q4]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
30-Dec-2012
Financial Year
2012
Quarter
31-Dec-2012 [#Q4]
Profit Trend
QoQ- 17.19%
YoY-
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
31/12/15 31/12/14 31/12/13 31/12/12 31/12/02 31/12/01 31/12/00 CAGR
Revenue 0 0 0 0 0 0 1 -
PBT -13,122 -9,457 -9,689 -2,775 -6,619 -6,344 -6,803 4.47%
Tax 287 135 47 476 692 -112 1,233 -9.25%
NP -13,122 -9,457 -9,689 -2,775 -6,619 -6,344 -5,565 5.88%
Tax Rate - - - - - - - -
Total Cost 13,122 9,457 9,689 2,775 6,619 6,344 5,566 5.88%
Ratio Analysis
31/12/15 31/12/14 31/12/13 31/12/12 31/12/02 31/12/01 31/12/00 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 -556,500.00 -
Per Share
31/12/15 31/12/14 31/12/13 31/12/12 31/12/02 31/12/01 31/12/00 CAGR
EPS -0.58 -0.49 -0.63 -0.29 -1.58 -1.57 -2.65 -9.62%
EPS Diluted -0.58 -0.49 -0.63 -0.29 -1.58 -1.57 -2.65 -9.62%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.